ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Role of SGLT-2 Inhibitors in Treatment of Patients with Type 2 Diabetes and NAFLD

Journal: International Journal of Clinical Dermatology & Research (IJCDR) (Vol.10, No. 01)

Publication Date:

Authors : ;

Page : 279-283

Keywords : Fatty Liver; Sodium-Glucose Cotransporter-2 Inhibitors; Diabetes; Liver Biopsy;

Source : Downloadexternal Find it from : Google Scholarexternal


Background: The role of sodium-glucose cotransporters-2 (SGLT-2) inhibitors in treatment of non-alcoholic fatty liver disease (NAFLD) is unclear. Objective: To examine the possible therapeutic role of SGLT-2 inhibitors in patients with type 2 diabetes and NAFLD. Methods: Pubmed search of English literature up to February 17, 2022. Search terms are fatty liver, SGLT-2, sodium-glucose cotransporter-2 inhibitors, diabetes, weight loss, liver biopsy. Randomized studies are reviewed with focus placed on doubleblind, placebo-controlled trials. Meta-analyses and pertinent reviews are also included.

Last modified: 2022-04-13 21:14:09